Patents by Inventor Kam Ming Ko

Kam Ming Ko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140358094
    Abstract: The present invention is a herbal composition and method of preparing thereof. The herbal composition comprising extracts of Carthami Flos (CF), Dipsaci Radix (DR), Notoginseng Rhizoma (NR) and Rhei Rhizoma (RR). The present invention also relates to an oil-in-water or water-in-oil type nano-emulsion and method of preparing thereof. The nano-emulsion comprises an aqueous phase, an organic phase and a surfactant, wherein said aqueous phase comprises hydrophilic extract of herbal materials and said organic phase comprises hydrophobic extract of said herbal materials. The present invention also relates to a transdermal patch comprises said nano-emulsion. The herbal composition of the present invention is useful in treating traumatic injuries, in particular bone injuries. The present nano-emulsion and patch thereof can promote skin absorption of active ingredients in herb, thereby increasing the herb's bioavailability and efficacy in therapy.
    Type: Application
    Filed: May 29, 2014
    Publication date: December 4, 2014
    Applicant: Nano and Advanced Materials Institute Limited
    Inventors: Ka Wing LAM, Chun Hay KO, Wing Sum SIU, Clara Bik San LAU, Tai Wai David LAU, Kam Ming KO, Ka Ming NG, Ping Chung LEUNG
  • Patent number: 7531195
    Abstract: The present invention provides a composition (e.g., a pharmaceutical composition) for reducing aging-related mitochondrial antioxidant status changes in a subject, wherein the composition comprises Schisandrin B. The present invention further provides a composition (e.g., a pharmaceutical composition) for reducing ischemia-reperfusion injury in an aging subject, wherein the composition comprises Schisandrin B. Also provided are methods for reducing aging-related mitochondrial antioxidant status changes and/or for reducing ischemia-reperfusion injury in an aging subject using the same.
    Type: Grant
    Filed: March 17, 2008
    Date of Patent: May 12, 2009
    Assignee: The Hong Kong University of Science and Technology
    Inventor: Kam Ming Ko
  • Publication number: 20080167372
    Abstract: The present invention provides a composition (e.g., a pharmaceutical composition) for reducing aging-related mitochondrial antioxidant status changes in a subject, wherein the composition comprises Schisandrin B. The present invention further provides a composition (e.g., a pharmaceutical composition) for reducing ischemia-reperfusion injury in an aging subject, wherein the composition comprises Schisandrin B. Also provided are methods for reducing aging-related mitochondrial antioxidant status changes and/or for reducing ischemia-reperfusion injury in an aging subject using the same.
    Type: Application
    Filed: March 17, 2008
    Publication date: July 10, 2008
    Applicant: The Hong Kong University of Science and Technology
    Inventor: Kam Ming Ko
  • Patent number: 7396544
    Abstract: The present invention provides a composition (e.g., a pharmaceutical composition) for reducing aging-related mitochondrial antioxidant status changes in a subject, wherein the composition comprises Schisandrin B. The present invention further provides a composition (e.g., a pharmaceutical composition) for reducing ischemia-reperfusion injury in an aging subject, wherein the composition comprises Schisandrin B. Also provided are methods for reducing aging-related mitochondrial antioxidant status changes and/or for reducing ischemia-reperfusion injury in an aging subject using the same.
    Type: Grant
    Filed: April 4, 2007
    Date of Patent: July 8, 2008
    Assignee: The Hong Kong University of Science and Technology
    Inventor: Kam Ming Ko
  • Patent number: 7276257
    Abstract: The present invention provides a preparation for treatment or prevention of a condition in a patient, said preparation comprising Schisandrin B. The concentration of Schisandrin B in the preparation may be between about 0.01 and about 0.1%, or it may be between about 20 and about 40% w/w or w/v. The preparation may additionally comprise one or more components selected from the group consisting of herbal extracts, fluids, solvents, antioxidants, preservatives, electrolytes, salts and pH control agents.
    Type: Grant
    Filed: July 22, 2005
    Date of Patent: October 2, 2007
    Assignee: The Hong Kong University of Science and Technology
    Inventor: Kam Ming Ko